Basic Information
RNALocate ID: | RLID:11001794 |
RNA Symbol: | hsa-miR-142-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-142-3p |
RNA ID: | miRBase:MIMAT0000434 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 19951903 |
Tissue/Cell Line: | Plasma |
Method: | Microarray |
Originally published in Gut. Zhou Q, et al, 2010. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | We found several miRNAs whose expression was consistently up-regulated in blood microvesicles samples from IBS patients with increased membrane permeability compared to controls (Figure 2A-lower, left panel). Three up-regulated miRNAs with a p<0.001 were identified: miR-142-3p, miRNA-29a and miR-148b (Figure 2A-lower, left panel). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001786 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
RLID:11001787 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001788 | Exosome | Breast milk | 22211110 |
RLID:11001789 | Exosome | Serum | 22427800 |
RLID:11001790 | Exosome | Brain tissue | 23382797 |
RLID:11001791 | Exosome | Plasma | 23663360 |
RLID:11001792 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001795 | Microvesicle | Liver resident stem cells | 20668554 |
RLID:11001796 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000084 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Lymphoma tissue|Mast cells | |
RLID-D:11000362 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-142-3p | Mantle cell lymphoma | MNDR-E-MI-13915 |
MNDR | hsa-miR-142-3p | Splenic marginal zone lymphoma | MNDR-E-MI-13916 |
MNDR | hsa-miR-142-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-13917 |
MNDR | hsa-miR-142-3p | Oral squamous cell carcinoma | MNDR-E-MI-13918 |
MNDR | hsa-miR-142-3p | Medulloblastoma | MNDR-E-MI-13919 |
MNDR | hsa-miR-142-3p | B cell lymphoma of malt type | MNDR-E-MI-13920 |
MNDR | hsa-miR-142-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-13921 |
MNDR | hsa-miR-142-3p | Lymphoma | MNDR-E-MI-13922 |
MNDR | hsa-miR-142-3p | Lymphoma non-hodgkin | MNDR-E-MI-13923 |
MNDR | hsa-miR-142-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-13924 |
MNDR | hsa-miR-142-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-13925 |
MNDR | hsa-miR-142-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-13926 |
MNDR | hsa-miR-142-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-13927 |
MNDR | hsa-miR-142-3p | Her2-receptor positive breast cancer | MNDR-E-MI-13928 |
MNDR | hsa-miR-142-3p | Breast cancer luminal | MNDR-E-MI-13929 |
MNDR | hsa-miR-142-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-13930 |
MNDR | hsa-miR-142-3p | Dermatomyositis | MNDR-E-MI-13931 |
MNDR | hsa-miR-142-3p | Prostate cancer | MNDR-E-MI-13932 |
MNDR | hsa-miR-142-3p | Hirschsprung disease | MNDR-E-MI-13933 |
MNDR | hsa-miR-142-3p | Gastric cancer | MNDR-E-MI-13934 |
MNDR | hsa-miR-142-3p | Pre-eclampsia | MNDR-E-MI-13935 |
MNDR | hsa-miR-142-3p | Alzheimer disease | MNDR-E-MI-13936 |
MNDR | hsa-miR-142-3p | Sarcoma | MNDR-E-MI-13937 |
MNDR | hsa-miR-142-3p | Dysautonomia familial | MNDR-E-MI-13938 |
MNDR | hsa-miR-142-3p | Leukemia | MNDR-E-MI-13939 |
MNDR | hsa-miR-142-3p | Huntington disease | MNDR-E-MI-13940 |
MNDR | hsa-miR-142-3p | Chorea | MNDR-E-MI-13941 |
MNDR | hsa-miR-142-3p | Cardiovascular disease | MNDR-E-MI-13942 |
MNDR | hsa-miR-142-3p | Moyamoya disease | MNDR-E-MI-13943 |
MNDR | hsa-miR-142-3p | Lung cancer | MNDR-E-MI-13944 |
MNDR | hsa-miR-142-3p | Down syndrome | MNDR-E-MI-13945 |
MNDR | hsa-miR-142-3p | Parkinson disease | MNDR-E-MI-13946 |
MNDR | hsa-miR-142-3p | Basal-like breast cancer | MNDR-E-MI-13947 |
MNDR | hsa-miR-142-3p | Thyroid cancer | MNDR-E-MI-13948 |
MNDR | hsa-miR-142-3p | Pituitary neoplasms | MNDR-E-MI-13949 |
MNDR | hsa-miR-142-3p | Pancreatic cancer | MNDR-E-MI-13950 |
MNDR | hsa-miR-142-3p | Melanoma | MNDR-E-MI-13951 |
MNDR | hsa-miR-142-3p | Rectum adenocarcinoma | MNDR-E-MI-13952 |
MNDR | hsa-miR-142-3p | Colon cancer | MNDR-E-MI-13953 |
MNDR | hsa-miR-142-3p | Ischemic attack transient | MNDR-E-MI-13954 |
MNDR | hsa-miR-142-3p | Colon adenocarcinoma | MNDR-E-MI-13955 |
MNDR | hsa-miR-142-3p | Multiple sclerosis | MNDR-E-MI-13956 |
MNDR | hsa-miR-142-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-13957 |
MNDR | hsa-miR-142-3p | Familial ovarian cancer | MNDR-E-MI-13958 |
MNDR | hsa-miR-142-3p | Asthma | MNDR-E-MI-13959 |
MNDR | hsa-miR-142-3p | Endometriosis | MNDR-E-MI-13960 |
MNDR | hsa-miR-142-3p | Carcinoma ductal breast | MNDR-E-MI-13961 |
MNDR | hsa-miR-142-3p | Glioblastoma | MNDR-E-MI-13962 |
MNDR | hsa-miR-142-3p | Astrocytoma | MNDR-E-MI-13963 |
MNDR | hsa-miR-142-3p | Malignant glioma | MNDR-E-MI-13964 |
MNDR | hsa-miR-142-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-13965 |
MNDR | hsa-miR-142-3p | Osteosarcoma | MNDR-E-MI-13966 |
MNDR | hsa-miR-142-3p | Liposarcoma | MNDR-E-MI-13967 |
MNDR | hsa-miR-142-3p | Breast carcinoma | MNDR-E-MI-13968 |
MNDR | hsa-miR-142-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-13969 |
MNDR | hsa-miR-142-3p | Meningioma | MNDR-E-MI-13970 |
MNDR | hsa-miR-142-3p | Uterine cancer | MNDR-E-MI-13971 |
MNDR | hsa-miR-142-3p | Gastric adenocarcinoma | MNDR-E-MI-13972 |
MNDR | hsa-miR-142-3p | Cervical squamous cell carcinoma | MNDR-E-MI-13973 |
MNDR | hsa-miR-142-3p | Pituitary adenoma | MNDR-E-MI-13974 |
MNDR | hsa-miR-142-3p | Lung squamous cell carcinoma | MNDR-E-MI-13975 |
MNDR | hsa-miR-142-3p | Carcinoma lung non-small-cell | MNDR-E-MI-13976 |
MNDR | hsa-miR-142-3p | Lung adenocarcinoma | MNDR-E-MI-13977 |
MNDR | hsa-miR-142-3p | Thyroid carcinoma | MNDR-E-MI-13978 |
MNDR | hsa-miR-142-3p | Bladder urothelial carcinoma | MNDR-E-MI-13979 |
MNDR | hsa-miR-142-3p | Pancreatic adenocarcinoma | MNDR-E-MI-13980 |
MNDR | hsa-miR-142-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-13981 |
MNDR | hsa-miR-142-3p | Carcinoma renal cell | MNDR-E-MI-13982 |
MNDR | hsa-miR-142-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-13983 |
MNDR | hsa-miR-142-3p | Clear cell renal cell carcinoma | MNDR-E-MI-13984 |
MNDR | hsa-miR-142-3p | Cholangiocarcinoma | MNDR-E-MI-13985 |
MNDR | hsa-miR-142-3p | Prolactinoma | MNDR-E-MI-13986 |
MNDR | hsa-miR-142-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-13987 |
MNDR | hsa-miR-142-3p | Testicular germ cell cancer | MNDR-E-MI-13988 |
MNDR | hsa-miR-142-3p | Kidney diseases | MNDR-E-MI-13989 |
MNDR | hsa-miR-142-3p | T-cell acute lymphoblastic leukemia | MNDR-E-MI-13990 |
MNDR | hsa-miR-142-3p | Fibromyalgia | MNDR-E-MI-13991 |
MNDR | hsa-miR-142-3p | Breast invasive carcinoma | MNDR-E-MI-13992 |
MNDR | hsa-miR-142-3p | Hepatocellular carcinoma | MNDR-E-MI-13993 |
MNDR | hsa-miR-142-3p | Embryonal cancer | MNDR-E-MI-13994 |
MNDR | hsa-miR-142-3p | Familiar ovarian carcinoma | MNDR-E-MI-13995 |
MNDR | hsa-miR-142-3p | B-cell lymphoma | MNDR-E-MI-13996 |
MNDR | hsa-miR-142-3p | Rheumatoid arthritis | MNDR-E-MI-13997 |
MNDR | hsa-miR-142-3p | Osteoarthritis | MNDR-E-MI-13998 |
MNDR | hsa-miR-142-3p | Hodgkin lymphoma | MNDR-E-MI-13999 |
MNDR | hsa-miR-142-3p | Ulcerative colitis | MNDR-E-MI-14000 |
MNDR | hsa-miR-142-3p | Burkitt lymphoma | MNDR-E-MI-14001 |
MNDR | hsa-miR-142-3p | Tonsil cancer | MNDR-E-MI-14002 |
MNDR | hsa-miR-142-3p | Neuromyelitis optica | MNDR-E-MI-14003 |
MNDR | hsa-miR-142-3p | Psoriasis | MNDR-E-MI-14004 |
MNDR | hsa-miR-142-3p | Skin cutaneous melanoma | MNDR-E-MI-14005 |
MNDR | hsa-miR-142-3p | Skin melanoma | MNDR-E-MI-14006 |
MNDR | hsa-miR-142-3p | Acute myeloid leukemia | MNDR-E-MI-14007 |
MNDR | hsa-miR-142-3p | Colorectal cancer | MNDR-E-MI-14008 |
MNDR | hsa-miR-142-3p | Nasopharyngeal carcinoma | MNDR-E-MI-14009 |
MNDR | hsa-miR-142-3p | Nasopharynx carcinoma | MNDR-E-MI-14010 |
MNDR | hsa-miR-142-3p | Multiple myeloma | MNDR-E-MI-14011 |
MNDR | hsa-miR-142-3p | Acute lymphoblastic leukemia | MNDR-E-MI-14012 |
MNDR | hsa-miR-142-3p | Ependymoma | MNDR-E-MI-14013 |
MNDR | hsa-miR-142-3p | Nasopharyngeal cancer | MNDR-E-MI-14014 |
MNDR | hsa-miR-142-3p | Prostatic neoplasms | MNDR-E-MI-14015 |
MNDR | hsa-miR-142-3p | Aids dementia complex | MNDR-E-MI-14016 |
MNDR | hsa-miR-142-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-14017 |
MNDR | hsa-miR-142-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-14018 |
MNDR | hsa-miR-142-3p | Stroke lacunar | MNDR-E-MI-14019 |
MNDR | hsa-miR-142-3p | Breast cancer her3+ negative | MNDR-E-MI-14020 |
MNDR | hsa-miR-142-3p | Multiple sclerosis susceptibility | MNDR-E-MI-14021 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG2 | Homo sapiens | RR00024737 |
TOP